Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis

J Clin Microbiol. 1990 Jul;28(7):1664-5. doi: 10.1128/jcm.28.7.1664-1665.1990.

Abstract

We report a case of Candida norvegensis invasive disease in an immunosuppressed renal transplant patient on continuous ambulatory peritoneal dialysis. Multiple cultures of peritoneal fluid, blood, and tracheal suction done over a 2-week period were positive for this unusual isolate. Despite treatment with amphotericin B and flucytosine the patient died. This is the first report of C. norvegensis fungemia documented by culture.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Blood / microbiology
  • Candida / drug effects
  • Candida / isolation & purification
  • Candidiasis / drug therapy
  • Candidiasis / etiology*
  • Drug Therapy, Combination / administration & dosage
  • Flucytosine / administration & dosage
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Kidney Failure, Chronic / complications
  • Male
  • Microbial Sensitivity Tests
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / drug therapy
  • Peritonitis / etiology*

Substances

  • Immunosuppressive Agents
  • Amphotericin B
  • Flucytosine